Newcastle researchers have revealed the first treatment to target the underlying cause of a rare kidney condition called "C3G ...

An MUSC research team reports in Cells that the complement system, part of the body’s natural immune defenses, is a key driver of inflammatory responses that contribute to fetal brain inflammation and ...

Newcastle researchers have revealed the first treatment to target the underlying cause of a rare kidney condition called “C3G ...

Newcastle researchers have revealed the first treatment to target the underlying cause of a rare kidney condition called “C3G ...

Sky's security and defence editor was left fighting for her life after falling ill with an ultra-rare condition. Today, on ...

With support from EDB and A*Star, Japanese biopharma leader Chugai is using its research base in Singapore to create new ...

During the last three months, 12 analysts shared their evaluations of Apellis Pharmaceuticals (NASDAQ: APLS), revealing diverse outlooks from bullish to bearish. The table below summarizes their ...

James Mason feels "empowered" thanks to his involvement in a pioneering clinical trial to find a treatment for a rare kidney ...

Oral bacteria viridans streptococci were found in over 60 percent of arterial plaques Biofilm-forming bacteria in plaque ...

The less time a tick has to feed, the less saliva it can pump in, and the fewer tricks it can use to tilt the odds. For ...

After decades without much movement, a handful of new treatments for this rare autoimmune disease are now approved, and ...